Charles S. Berkman

Overview

Charles S. Berkman received an average of $3M in total compensation, including $471K in salary, at OmniAb from 2021 to 2023. Charles Berkman also received an average of $1M at Ligand Pharmaceuticals from 2007 to 2021.

Related executives

We found nine more executives who work or worked at OmniAb and Ligand Pharmaceuticals.

Matthew Foehr

OmniAb

Chief Executive Officer

Kurt Gustafson

OmniAb

Chief Financial Officer

John Higgins

Ligand Pharmaceuticals

Chief Executive Officer

Matthew Korenberg

Ligand Pharmaceuticals

Chief Financial Officer

Nishan de Silva

Ligand Pharmaceuticals

Chief Financial Officer

Melanie Herman

Ligand Pharmaceuticals

Chief Financial Officer

John Sharp

Ligand Pharmaceuticals

Chief Financial Officer

Martin Meglasson

Ligand Pharmaceuticals

Vice President, Discovery Research

News

You may also like